Success stories Apr 23, 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
Aktuell Apr 30, 2024 Johnson & Johnson eröffnet Innovation Hub in Allschwil Johnson & Johnson hat im Switzerland Innovation Park Basel Area den ersten J&J Innovation Hub auf dem europäischen Festland eröffnet. Es stellt e...
News May 22, 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News May 24, 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
Actualités Apr 17, 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News May 21, 2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
Aktuell Mar 18, 2024 Sedimentum expandiert als Helpany in die USA Sedimentum benennt sich um in Helpany und expandiert nach San Francisco. Das Medtech-Start-up präsentiert zugleich sein neues radargestütztes Sic...
News May 08, 2024 B. Braun Medical opens new factory in Sempach B. Braun Medical AG has commenced operations at a new production facility for disinfectant and hygiene products in Sempach. The company has inves...
News May 10, 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Actualités Jun 28, 2023 Unlimitrust : le campus vaudois dédié à l’économie de la confiance En réponse aux défis grandissants de la cybersécurité, SICPA a créé Unlimitrust, un campus dédié à l’innovation en confiance numérique pour un av...
News Nov 21, 2023 Quantum technologies in Western Switzerland Harnessing the promise of emerging quantum technologies, Western Switzerland is shaping up to be a pivotal region in this transformative field.
News May 17, 2022 ORIGYN Foundation partners with WatchBox to bring watchmaking into a new era ORIGYN, the Neuchâtel-based foundation dedicated to identifying, authenticating, and unlocking the powers of ownership for objects of value, has ...
News Apr 30, 2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
Actualités Jun 13, 2023 Le campus de l’économie de confiance de SICPA, unlimitrust, a été inauguré SICPA, leader mondial des encres de sécurité pour billets de banque et acteur majeur des solutions d’authentification, d’identification et de tra...
News Apr 23, 2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News Apr 15, 2024 First BOOM Summit deemed a success The organizers of the BOOM Summit are describing the first edition as a success. In total, 500 experts exchanged their knowledge and expertise at...